Most people think of optimism as a good thing - a positive outlook in challenging circumstances. But in reality, it's a psychological state that can be "contagious" in a bad way. A new study, published in the journal Psycho-Oncology, details how a seriously ill patient's optimism can impact a clinician's survival prognosis in palliative care conversations.
You are here
Scaling up the human papillomavirus (HPV) vaccine could eradicate cervical cancer in high-income countries within 30 years, with most other countries following by the end of the century, according to new research.
In 2018, there were 570,000 new cases of cervical cancer, which represented 6.6% of all female cancers. The World Health Organization (WHO) stated that around 90% of these deaths occurred in low- and middle-income countries.
Dying cancer patients given fluids will generally live longer, a new study led by researchers from Royal Surrey County Hospital NHS Foundation Trust and the University of Surrey has found.
End-of-life patients receiving assisted hydration had a 26 per cent greater survival, which meant that they lived for on average one-and-a-half more days, compared to those who were not receiving such treatment.
Over a year more than 200 cancer patients, who were in the last week of their life, took part in the study at four cancer centers and eight hospices across the country.
A team of scientists led by Virginia Commonwealth University physicist Jason Reed, Ph.D., have developed new nanomapping technology that could transform the way disease-causing genetic mutations are diagnosed and discovered. Described in a study published today in the journal Nature Communications, this novel approach uses high-speed atomic force microscopy (AFM) combined with a CRISPR-based chemical barcoding technique to map DNA nearly as accurately as DNA sequencing while processing large sections of the genome at a much faster rate.